We have located links that may give you full text access.
miR-451 selectively increases sensitivity to cisplatin in ERCC1-high non-small cell lung cancer cells.
Journal of Cellular Biochemistry 2018 January 7
Lung cancer is the leading cause of cancer-related death throughout the world and cisplatin chemoresistance is one of the major hindrances of efficiency in this malignancy therapy. It has been reported that miR-451, a tumor suppressor, is involved in sensitivity of cancer cells to cisplatin. However, the role of miR-451 in chemosensitivity of lung cancer cells and the underlying mechanism still remains to be not fully illuminated. We first assessed the expression of ERCC1 and miR-451 in six NSCLS cell lines and NHBE cells by qRT-PCR. Then ERCC1-low and ERCC1-high NSCLC cells were transfected with miR-451 mimic and mimic control. And cell viability, apoptotic cell rates, and migration activity was respectively measured by CCK-8 assay, flow cytometry, and wound healing assay. The expression of ERCC1, Wnt/β-catenin and PI3K/AKT pathway related factors were measured by western blot. The expression of miR-451 was higher in ERCC1-low NSCLC cells, while lower in ERCC1-high NSCLC cells. miR-451 overexpression inhibited the expression of ERCC1 in ERCC1-high NSCLC cells. Furthermore, miR-451 overexpression selectively enhanced cisplatin sensitivity in ERCC1-high NSCLC cells, as evidenced by reduction of cell viability with a dose manner. We further found that miR-451 overexpression significantly inhibited cell migration in ERCC1-high NSCLC cells. Interesting, Wnt/β-catenin and PI3K/AKT pathways were inhibited by miR-451 overexpression. This study demonstrates that miR-451 selectively promotes sensitivity to cisplatin in ERCC1-high NSCLC cells. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app